Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTERNATIONAL FLAVORS & FRAGRANCES INCIFF · Entity 3234 | Pres. Health & Bioscience | March 04, 2025 | March 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTERNATIONAL FLAVORS & FRAGRANCES INC
Report date March 04, 2025 · Filed March 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,841.324 |
Reported balance
After 2025-03-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-03-04 · Grant · Acquired 237 · Balance 10,841.324 F1: These shares represent the 50% portion of the reporting person's payout under the 2022-2024 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 1, 2022, the first stock trading day of the LTIP cycle. |
| Common StockSEC Table I · non-derivative | Direct | 10,755.324 |
Reported balance
After 2025-03-04 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2025-03-04 · Tax withholding · Disposed 86 · Balance 10,755.324 F2: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP. F3: Includes shares acquired during the period pursuant to a dividend reinvestment plan. The transactions were exempt pursuant to Rule 16a-11. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent the 50% portion of the reporting person's payout under the 2022-2024 Long Term Incentive Plan ("LTIP") cycle settled in shares of the issuer's common stock. The number of shares was determined based on the average closing market price of the issuer's common stock for the twenty trading days prior to January 1, 2022, the first stock trading day of the LTIP cycle.
F2: Shares withheld to satisfy tax withholding obligations in connection with the receipt of shares under the LTIP.
F3: Includes shares acquired during the period pursuant to a dividend reinvestment plan. The transactions were exempt pursuant to Rule 16a-11.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Tax withholdingCommon Stock | 35 | $136.21 | $4,767.35 |
DisclosureSEC source: 0001225208-21-002882 · doc4.xml · nonDerivative · entry 4 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 02:14 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionCommon Stock | 105 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002882 · doc4.xml · nonDerivative · entry 3 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Reflects vesting and settlement of RSUs granted on February 15, 2018. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 15, 2021 Filed Jun 2, 2021 20:46 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Tax withholdingCommon Stock | 27 | $136.21 | $3,677.67 |
DisclosureSEC source: 0001225208-21-008817 · doc4a.xml · nonDerivative · entry 2 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 952 F1 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Number of shares withheld was misreported due to administrative error. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionRestricted Stock Units · Derivative | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002882 · doc4.xml · derivative · entry 5 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,122 Underlying: Common Stock · 525 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. F5 · derivative.exercise_date: The RSUs vested on February 14, 2021. F5 · derivative.expiration_date: The RSUs vested on February 14, 2021. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Tax withholdingCommon Stock | 173 | $136.21 | $23,564.33 |
DisclosureSEC source: 0001225208-21-002882 · doc4.xml · nonDerivative · entry 2 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352 F3 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Read SEC document |
| February 14, 2021 Filed Feb 18, 2021 02:14 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionCommon Stock | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002882 · doc4.xml · nonDerivative · entry 1 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F2 · price: The RSUs convert to Common Stock on a one-for-one basis. Read SEC document |
| February 14, 2021 Filed Feb 19, 2021 23:59 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Exercise / conversionRestricted Stock Units · Derivative | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003224 · doc4a.xml · derivative · entry 1 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,374 Underlying: Common Stock · 525 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The RSUs convert to Common Stock on a one-for-one basis. F2 · shares: Reflects vesting and settlement of Restricted Stock Units ("RSUs") granted on February 14, 2019. F1 · price: The RSUs convert to Common Stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs vested on February 14, 2021. F3 · derivative.expiration_date: The RSUs vested on February 14, 2021. F4 · balance_after: Number of RSUs was misreported due to administrative error. Read SEC document |
| February 14, 2021 Filed Jun 2, 2021 20:46 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | Tax withholdingCommon Stock | 132 | $136.21 | $17,979.72 |
DisclosureSEC source: 0001225208-21-008817 · doc4a.xml · nonDerivative · entry 1 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 874 F1 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs. Number of shares withheld was misreported due to administrative error. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 11,702 | Not disclosed Strike: $95.28 | Not disclosed |
DisclosureSEC source: 0001225208-21-001613 · doc4.xml · derivative · entry 9 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,702 Underlying: Common Stock · 11,702 shares Expires 2029-08-05 F5 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 1,513 | Not disclosed Strike: $115.48 | Not disclosed |
DisclosureSEC source: 0001225208-21-001613 · doc4.xml · derivative · entry 8 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,513 Underlying: Common Stock · 1,513 shares Expires 2022-02-03 F5 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 9,606 | Not disclosed Strike: $123.76 | Not disclosed |
DisclosureSEC source: 0001225208-21-001613 · doc4.xml · derivative · entry 7 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,606 Underlying: Common Stock · 9,606 shares Expires 2027-02-01 F5 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 8,469 | Not disclosed Strike: $77.16 | Not disclosed |
DisclosureSEC source: 0001225208-21-001613 · doc4.xml · derivative · entry 6 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,469 Underlying: Common Stock · 8,469 shares Expires 2030-02-18 F5 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. F6 · derivative.exercise_date: Options will vest and become exercisable in three equal tranches with respect to 2,823 shares of Common Stock on each of February 19, 2021, 2022 and 2023, subject to contiued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 4,068 | Not disclosed Strike: $149.65 | Not disclosed |
DisclosureSEC source: 0001225208-21-001613 · doc4.xml · derivative · entry 5 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,068 Underlying: Common Stock · 4,068 shares Expires 2028-02-14 F5 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. F4 · derivative.exercise_date: Option is exercisable as of the date of replacement with respect to 2,712 shares of Common Stock. The Option will become exercisable in respect of the remaining 1,356 shares of Common Stock on February 15, 2021, subject to continued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 3,241 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-21-001613 · doc4.xml · derivative · entry 4 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,241 Underlying: Common Stock · 3,241 shares Expires 2021-12-31 F1 · derivative.exercise_price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F1 · price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 105 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-21-001613 · doc4.xml · derivative · entry 3 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105 Underlying: Common Stock · 105 shares Expires 2021-02-15 F1 · derivative.exercise_price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F1 · price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 2,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-21-001613 · doc4.xml · derivative · entry 2 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,647 Underlying: Common Stock · 2,100 shares Expires not disclosed F1 · derivative.exercise_price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F1 · price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: RSU vests with respect to 1,050 shares of Common Stock on each of February 14, 2021 and 2022, subject to continued employment with IFF. F3 · derivative.expiration_date: RSU vests with respect to 1,050 shares of Common Stock on each of February 14, 2021 and 2022, subject to continued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 22:58 UTC | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 5,547 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-21-001613 · doc4.xml · derivative · entry 1 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,547 Underlying: Common Stock · 5,547 shares Expires not disclosed F1 · derivative.exercise_price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F1 · price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 1,849 shares of Common Stock on each of February 19, 2021, 2022 and 2023, subject to continued employment with IFF. F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 1,849 shares of Common Stock on each of February 19, 2021, 2022 and 2023, subject to continued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 19, 2021 23:56 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 3,202 | Not disclosed Strike: $123.76 | Not disclosed |
DisclosureSEC source: 0001225208-21-003221 · doc4a.xml · derivative · entry 5 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,202 Underlying: Common Stock · 3,202 shares Expires 2027-02-01 F5 · shares: Number of Options was misreported due to administrative error. F7 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. Read SEC document |
| February 01, 2021 Filed Feb 19, 2021 23:56 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 2,823 | Not disclosed Strike: $77.16 | Not disclosed |
DisclosureSEC source: 0001225208-21-003221 · doc4a.xml · derivative · entry 4 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,823 Underlying: Common Stock · 2,823 shares Expires 2030-02-18 F5 · shares: Number of Options was misreported due to administrative error. F7 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. F8 · derivative.exercise_date: Options will vest and become exercisable in three equal tranches on each of February 19, 2021, 2022 and 2023, subject to contiued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 19, 2021 23:56 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantStock Options (right to buy) · Derivative | 1,356 | Not disclosed Strike: $149.65 | Not disclosed |
DisclosureSEC source: 0001225208-21-003221 · doc4a.xml · derivative · entry 3 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,356 Underlying: Common Stock · 1,356 shares Expires 2028-02-14 F5 · shares: Number of Options was misreported due to administrative error. F7 · price: In connection with the Transactions, DuPont options were replaced with Options to purchase Common Stock. F6 · derivative.exercise_date: Option is exercisable as of the date of replacement with respect to 904 shares of Common Stock. The Option will become exercisable in respect of the remaining 452 shares of Common Stock on February 15, 2021, subject to continued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 19, 2021 23:56 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 1,050 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-21-003221 · doc4a.xml · derivative · entry 2 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,899 Underlying: Common Stock · 1,050 shares Expires not disclosed F1 · derivative.exercise_price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F2 · shares: Number of RSUs was misreported due to administrative error. F1 · price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F4 · derivative.exercise_date: RSUs vest in two equal tranches on each of February 14, 2021 and 2022, subject to continued employment with IFF. F4 · derivative.expiration_date: RSUs vest in two equal tranches on each of February 14, 2021 and 2022, subject to continued employment with IFF. Read SEC document |
| February 01, 2021 Filed Feb 19, 2021 23:56 UTC Amendment | INTERNATIONAL FLAVORS & FRAGRANCES INC IFF · Entity 3234 | GrantRestricted Stock Units · Derivative | 1,849 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-21-003221 · doc4a.xml · derivative · entry 1 Herriott Simon · CIK 0001843592 · President Health & Biosciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,849 Underlying: Common Stock · 1,849 shares Expires not disclosed F1 · derivative.exercise_price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F2 · shares: Number of RSUs was misreported due to administrative error. F1 · price: In connection with the combination of IFF and the Nutrition & Biosciences business ("N&B") of DuPont de Nemours, Inc. ("DuPont") (the "Transactions"), DuPont restricted stock units were replaced with Restricted Stock Units ("RSUs") that convert into Common Stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: RSUs vest in three equal tranches on each of February 19, 2021, 2022 and 2023, subject to continued employment with IFF. F3 · derivative.expiration_date: RSUs vest in three equal tranches on each of February 19, 2021, 2022 and 2023, subject to continued employment with IFF. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.